Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis

10 Oct 2022

Abstract excerpt

Several biomarkers from multiple sclerosis (MS) patients' biological fluids have been considered to support diagnosis, predict disease course, and evaluate treatment response. In this study, we assessed the CSF concentration of selected molecules implicated in the MS pathological process. To investigate the diagnostic and prognostic significance of CSF concentration of target candidate biomarkers in both...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Sclerosis Research Studies
Share to Viral Infections and Immunology Research
Share to Virology and Viral Diseases

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36215027
DOI: 10.1007/s12035-022-03060-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple SclerosisPMID 36215027Read ↗

Correlation of selected serum protein levels with the degree of disability and NEDA-3 status in multiple sclerosis phenotypes.Semantic proximity Read ↗

Molecular markers in the CSF proteome differentiate neuroinflammatory diseasesSemantic proximity Read ↗

CSF chitinase 3-like-1 association with disability of primary progressive MSSemantic proximity Read ↗

Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.Semantic proximity Read ↗

Biomarkers of Therapeutic Response in Multiple Sclerosis: Current StatusSemantic proximity Read ↗

CXCL13 as a Biomarker: Background and Utility in Multiple SclerosisSemantic proximity Read ↗

Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.Semantic proximity Read ↗

The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review.Semantic proximity Read ↗

Proteomics reveal biomarkers for diagnosis, disease activity and long-term disability outcomes in multiple sclerosisSemantic proximity Read ↗

Potential biomarkers for multiple sclerosis stage from targeted proteomics and microRNA sequencingSemantic proximity Read ↗

Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosisSemantic proximity Read ↗

Plasma proteome in multiple sclerosis disease progressionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.